ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

XLM Xlmedia Plc

13.00
-0.25 (-1.89%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Xlmedia Plc LSE:XLM London Ordinary Share JE00BH6XDL31 ORD USD0.000001
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25 -1.89% 13.00 12.50 13.50 13.25 13.00 13.25 169,755 11:54:04
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Advertising, Nec 73.74M -9.44M -0.0359 -3.62 34.14M
Xlmedia Plc is listed in the Advertising sector of the London Stock Exchange with ticker XLM. The last closing price for Xlmedia was 13.25p. Over the last year, Xlmedia shares have traded in a share price range of 6.00p to 14.075p.

Xlmedia currently has 262,586,405 shares in issue. The market capitalisation of Xlmedia is £34.14 million. Xlmedia has a price to earnings ratio (PE ratio) of -3.62.

Xlmedia Share Discussion Threads

Showing 12576 to 12598 of 18200 messages
Chat Pages: Latest  512  511  510  509  508  507  506  505  504  503  502  501  Older
DateSubjectAuthorDiscuss
22/3/2021
13:32
Ta

Plenty of time. Small too £3m . Market cap is £118m so it wont even touch the price

john09
22/3/2021
13:30
40p Rights.
It's just gone up on the board at Barc's 1/26 + excess .... respond by 30/3/21.
f.

fillipe
22/3/2021
12:56
I haven’t got mine yet from iDealing
john09
22/3/2021
12:51
I've got holdings in xlm with interactive investor and also eqi. I received notification of corporate action from the former but not the latter. Anyone else had a similar problem with eqi?
iandippie
22/3/2021
11:00
Same here with H/L , WISH I bought more at 16.53p last March as SCSW and Techinvest suggested when lots of posters were rubbishing it
malcolmmm
22/3/2021
09:57
Showing in my AJB but no instruction re redeeming
ayl30
22/3/2021
09:53
No advice from either AJBell or HL as yet. I wait impatiently to take up my rights!
gerihatrick
22/3/2021
09:48
FredD....... Thanks for that will try again now then :-)
cheshire man
22/3/2021
09:43
Nearly 3m shares traded again in less than 2 hours
john09
22/3/2021
09:24
YES, NINEDDOORS99...This may double...sportsbet
GLA

rem108
22/3/2021
09:23
Thanks ninedoors99

Ah ok simple then lol . Then yes also always better to look at forward PE than current. If your saying that current eps could be 6p (conservatively based on January) assume taking into account new shares? Then the current share price is way off the pace

———;

ninedoors9922 Mar '21 - 09:14 - 11818 of 11820
0 0 0
Just simply Used jan 2021 and x by 12

john09
22/3/2021
09:18
Cheshire,
Just taken up the offer on II at about 09.05. Only received the notification on Friday after 18.00

Edited typo on time

fredd
22/3/2021
09:15
The world waking up to the North America casino and sports betting affiliate here
john09
22/3/2021
09:14
Just simply Used jan 2021 and x by 12
ninedoors99
22/3/2021
09:14
Yep big volume again
john09
22/3/2021
09:04
And counting
jltaylor1001
22/3/2021
09:00
Boom up 6p !
john09
22/3/2021
08:59
Wow it's been a slow ship to turn but well done to all that waited
jltaylor1001
22/3/2021
08:59
Morning

How did you get to your EBITDA number?

john09
22/3/2021
08:43
Off to the races again folks
john09
22/3/2021
08:17
Big news

AstraZeneca’s US clinical trial of its Covid-19 vaccine developed with Oxford university has shown 79 per cent efficacy at preventing symptomatic disease and 100 per cent efficacy against severe or critical disease and hospitalisation.

A fifth of the participants in the trial were over the age of 65 and the jab showed 80 per cent efficacy in these older participants, the long-awaited results showed on Monday.

The AstraZeneca vaccine is currently embroiled in a safety row in Europe, with some countries pausing its rollout after registering a series of rare side events involving a specific type of blood clot.

The European regulator, the European Medicines Agency, has said throughout the safety crisis that the vaccine’s benefits far outweigh its risks, but some countries have opted to halt the rollout, pending more data.

Crucially, the US trial found the vaccine was well tolerated, AstraZeneca said, and the independent data safety monitoring board identified no safety concerns related to the vaccine.

john09
22/3/2021
08:08
II not allowing me to proceed with purchase,,,,,,,site down ??
cheshire man
22/3/2021
07:28
Expecting another good day here
john09
Chat Pages: Latest  512  511  510  509  508  507  506  505  504  503  502  501  Older

Your Recent History

Delayed Upgrade Clock